Interní Med. 2014; 16(1): 31-34

Young patient with recurrent deep vein thrombosis - causes and consequences

doc.MUDr.Jana Hirmerová, Ph.D.
II. interní klinika LF UK a FN Plzeň

The article describes a case report of a complicated course of venous thromboembolic disease. A young man was hospitalized in our

department in 2003 with suspected recurrence of deep vein thrombosis. Ultrasonograpy found multiple thrombotic changes in the

deep veins of both legs, probably of various duration. X-ray venography revealed chronic venous occlusion in pelvic veins bilaterally.

We started administration of low-molecular-weight heparin with transition to warfarin. However, drug-induced liver damage occurred

as a consequence of warfarin use. Moreover, we confirmed a strong combined hypercoagulable state. We recommended a long-term

anticoagulation with low-molecular-weight heparin. During follow-up, the patient has been several times treated for leg ulcer, associated

with advanced postthrombotic syndrome. Since 2012, he has been on long-term oral anticoagulation with rivaroxaban.

Keywords: deep vein thrombosis, hypercoagulable state, anticoagulation, postthrombotic syndrome

Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hirmerová J. Young patient with recurrent deep vein thrombosis - causes and consequences. Interní Med. 2014;16(1):31-34.
Download citation

References

  1. Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 2007; 92(2): 199-205. Go to original source... Go to PubMed...
  2. Ho WK, Hankey GJ, Quinlan DJ, et al. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med 2006; 166(7): 729-736. Go to original source... Go to PubMed...
  3. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125(1): 1-7. Go to original source... Go to PubMed...
  4. Hojensgard IC. Sequelae of deep thrombosis in the lower limbs; follow-up study of patients initially treated by conservative measures. Angiology 1952; 3(1): 42-47. Go to original source... Go to PubMed...
  5. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003; 349(5): 474-485. Go to original source... Go to PubMed...
  6. Foy P, Moll S. Thrombophilia: 2009 update. Curr Treat Options Cardiovasc Med 2009; 11(2): 114-128. Go to original source... Go to PubMed...
  7. The Einstein Investigators. Oral Rivaroxaban for Symptomatic Venous Thromboembolism. N Engl J Med 2010; 363: 2499-510. Go to original source... Go to PubMed...
  8. Cohen AT, Dobromirski M. The Use of Rivaroxaban for Short- and Long-term Treatment of Venous Thromboembolism. Thromb Haemost 2012; 107: 1035-1043. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.